Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$Adma生物制品(ADMA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-22-016598 Act: 34 Size: 5 MB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-011249 Size: 9 KB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-011251 Size: 7 KB 网页链接
$Adma生物制品(ADMA)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-22-011213 Act: 34 Size: 229 KB 网页链接
$Adma生物制品(ADMA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001140361-22-011030 Act: 34 Size: 10 MB 网页链接
$Adma生物制品(ADMA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-22-011028 Act: 34 Size: 462 KB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-008676 Size: 8 KB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-008677 Size: 7 KB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-008670 Size: 10 KB 网页链接
$Adma生物制品(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-22-008671 Size: 11 KB 网页链接